FindTrial
Sign In

Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin Treatment

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00213070
Enrollment
Unknown
Registered
2005-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2006-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Keywords

alpha-glucosidase inhibitor,Insulin

Brief summary

The purpose of this study is evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus with treated insulin.

Interventions

DRUGMiglitol

Sponsors

Sanwa Kagaku Kenkyusho Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Type2 diabetes * Criteria of postprandial plasma glucose and HbA1c are met

Exclusion criteria

* Type1 diabetes * Patients with antidiabetic drugs * The other

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026